Here, in critical COVID-19 patients, the genes involved in type I IFN signaling (such as IFNAR1, JAK1, TYK2) were upregulated, whereas the IFN-stimulated genes (ISGs) (such as MX1, IFITM1, IFIT2) were dramatically downregulated. The gene discussed is IFNA1; the disease is COVID-19.